PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT
The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a the...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SHIRAISHI, Takuya YOSHINO, Hitoshi NISHIMOTO, Masahiro TANIDA, Satoshi AOKI, Masahide KAWAI, Takahiro TSUCHIYA, Satoshi KASHIWAGI, Hirotaka KAMON, Takuma HORI, Nobuyuki NISHIMURA, Yoshikazu OGURI, Kyoko MATSUO, Atsushi SATO, Tsutomu OGAWA, Hiroko FURUTA, Yoshiyuki YOSHIDA, Shoshin |
| description | The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a therapeutic agent for non-insulin-dependent diabetes mellitus (Type 2 diabetes) or obesity containing such compound, salt or solvate as an active ingredient. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024262824A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024262824A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024262824A13</originalsourceid><addsrcrecordid>eNrjZHAIiAxyjPL38QfSni6efq4KLq5BnmGOIZ5hrgoejmGefu4K7j4BuoYKQa7OrgEh_kEKju7-fp7BIQqubm6uziE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-NNjIwMjEyMzIwsjE0dCYOFUAgq8r1g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT</title><source>esp@cenet</source><creator>SHIRAISHI, Takuya ; YOSHINO, Hitoshi ; NISHIMOTO, Masahiro ; TANIDA, Satoshi ; AOKI, Masahide ; KAWAI, Takahiro ; TSUCHIYA, Satoshi ; KASHIWAGI, Hirotaka ; KAMON, Takuma ; HORI, Nobuyuki ; NISHIMURA, Yoshikazu ; OGURI, Kyoko ; MATSUO, Atsushi ; SATO, Tsutomu ; OGAWA, Hiroko ; FURUTA, Yoshiyuki ; YOSHIDA, Shoshin</creator><creatorcontrib>SHIRAISHI, Takuya ; YOSHINO, Hitoshi ; NISHIMOTO, Masahiro ; TANIDA, Satoshi ; AOKI, Masahide ; KAWAI, Takahiro ; TSUCHIYA, Satoshi ; KASHIWAGI, Hirotaka ; KAMON, Takuma ; HORI, Nobuyuki ; NISHIMURA, Yoshikazu ; OGURI, Kyoko ; MATSUO, Atsushi ; SATO, Tsutomu ; OGAWA, Hiroko ; FURUTA, Yoshiyuki ; YOSHIDA, Shoshin</creatorcontrib><description>The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a therapeutic agent for non-insulin-dependent diabetes mellitus (Type 2 diabetes) or obesity containing such compound, salt or solvate as an active ingredient.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=US&NR=2024262824A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=US&NR=2024262824A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHIRAISHI, Takuya</creatorcontrib><creatorcontrib>YOSHINO, Hitoshi</creatorcontrib><creatorcontrib>NISHIMOTO, Masahiro</creatorcontrib><creatorcontrib>TANIDA, Satoshi</creatorcontrib><creatorcontrib>AOKI, Masahide</creatorcontrib><creatorcontrib>KAWAI, Takahiro</creatorcontrib><creatorcontrib>TSUCHIYA, Satoshi</creatorcontrib><creatorcontrib>KASHIWAGI, Hirotaka</creatorcontrib><creatorcontrib>KAMON, Takuma</creatorcontrib><creatorcontrib>HORI, Nobuyuki</creatorcontrib><creatorcontrib>NISHIMURA, Yoshikazu</creatorcontrib><creatorcontrib>OGURI, Kyoko</creatorcontrib><creatorcontrib>MATSUO, Atsushi</creatorcontrib><creatorcontrib>SATO, Tsutomu</creatorcontrib><creatorcontrib>OGAWA, Hiroko</creatorcontrib><creatorcontrib>FURUTA, Yoshiyuki</creatorcontrib><creatorcontrib>YOSHIDA, Shoshin</creatorcontrib><title>PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT</title><description>The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a therapeutic agent for non-insulin-dependent diabetes mellitus (Type 2 diabetes) or obesity containing such compound, salt or solvate as an active ingredient.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAIiAxyjPL38QfSni6efq4KLq5BnmGOIZ5hrgoejmGefu4K7j4BuoYKQa7OrgEh_kEKju7-fp7BIQqubm6uziE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-NNjIwMjEyMzIwsjE0dCYOFUAgq8r1g</recordid><startdate>20240808</startdate><enddate>20240808</enddate><creator>SHIRAISHI, Takuya</creator><creator>YOSHINO, Hitoshi</creator><creator>NISHIMOTO, Masahiro</creator><creator>TANIDA, Satoshi</creator><creator>AOKI, Masahide</creator><creator>KAWAI, Takahiro</creator><creator>TSUCHIYA, Satoshi</creator><creator>KASHIWAGI, Hirotaka</creator><creator>KAMON, Takuma</creator><creator>HORI, Nobuyuki</creator><creator>NISHIMURA, Yoshikazu</creator><creator>OGURI, Kyoko</creator><creator>MATSUO, Atsushi</creator><creator>SATO, Tsutomu</creator><creator>OGAWA, Hiroko</creator><creator>FURUTA, Yoshiyuki</creator><creator>YOSHIDA, Shoshin</creator><scope>EVB</scope></search><sort><creationdate>20240808</creationdate><title>PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT</title><author>SHIRAISHI, Takuya ; YOSHINO, Hitoshi ; NISHIMOTO, Masahiro ; TANIDA, Satoshi ; AOKI, Masahide ; KAWAI, Takahiro ; TSUCHIYA, Satoshi ; KASHIWAGI, Hirotaka ; KAMON, Takuma ; HORI, Nobuyuki ; NISHIMURA, Yoshikazu ; OGURI, Kyoko ; MATSUO, Atsushi ; SATO, Tsutomu ; OGAWA, Hiroko ; FURUTA, Yoshiyuki ; YOSHIDA, Shoshin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024262824A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SHIRAISHI, Takuya</creatorcontrib><creatorcontrib>YOSHINO, Hitoshi</creatorcontrib><creatorcontrib>NISHIMOTO, Masahiro</creatorcontrib><creatorcontrib>TANIDA, Satoshi</creatorcontrib><creatorcontrib>AOKI, Masahide</creatorcontrib><creatorcontrib>KAWAI, Takahiro</creatorcontrib><creatorcontrib>TSUCHIYA, Satoshi</creatorcontrib><creatorcontrib>KASHIWAGI, Hirotaka</creatorcontrib><creatorcontrib>KAMON, Takuma</creatorcontrib><creatorcontrib>HORI, Nobuyuki</creatorcontrib><creatorcontrib>NISHIMURA, Yoshikazu</creatorcontrib><creatorcontrib>OGURI, Kyoko</creatorcontrib><creatorcontrib>MATSUO, Atsushi</creatorcontrib><creatorcontrib>SATO, Tsutomu</creatorcontrib><creatorcontrib>OGAWA, Hiroko</creatorcontrib><creatorcontrib>FURUTA, Yoshiyuki</creatorcontrib><creatorcontrib>YOSHIDA, Shoshin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHIRAISHI, Takuya</au><au>YOSHINO, Hitoshi</au><au>NISHIMOTO, Masahiro</au><au>TANIDA, Satoshi</au><au>AOKI, Masahide</au><au>KAWAI, Takahiro</au><au>TSUCHIYA, Satoshi</au><au>KASHIWAGI, Hirotaka</au><au>KAMON, Takuma</au><au>HORI, Nobuyuki</au><au>NISHIMURA, Yoshikazu</au><au>OGURI, Kyoko</au><au>MATSUO, Atsushi</au><au>SATO, Tsutomu</au><au>OGAWA, Hiroko</au><au>FURUTA, Yoshiyuki</au><au>YOSHIDA, Shoshin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT</title><date>2024-08-08</date><risdate>2024</risdate><abstract>The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a therapeutic agent for non-insulin-dependent diabetes mellitus (Type 2 diabetes) or obesity containing such compound, salt or solvate as an active ingredient.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2024262824A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T08%3A36%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHIRAISHI,%20Takuya&rft.date=2024-08-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024262824A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |